Next |
home / stock / mrna / mrna message board
Subject | By | Source | When |
---|---|---|---|
Cathie Wood's ARK Innovation ETF buys shares of | axelvento | investorshub | 05/01/2023 4:39:04 AM |
Believe in what | Vexari | investorshub | 05/01/2023 4:25:38 AM |
the important thing is to believe not to hope! | axelvento | investorshub | 05/01/2023 4:14:06 AM |
The thought of overthinking without explanation | Vexari | investorshub | 04/30/2023 8:03:20 PM |
Without understanding | Vexari | investorshub | 04/29/2023 9:23:49 PM |
Making good personal choices in one's health care regimen | Vexari | investorshub | 04/29/2023 7:58:32 PM |
Germ ~~ virus theory is not a theory | Vexari | investorshub | 04/28/2023 11:38:41 PM |
Covid vaccine maker is sitting on $18bn and | axelvento | investorshub | 04/28/2023 4:18:00 AM |
For my second pick, I'm swinging for the | axelvento | investorshub | 04/28/2023 4:12:39 AM |
I find value in your desperation....over thinking! | axelvento | investorshub | 04/28/2023 3:24:38 AM |
Desperation, is beginning to show itself | Vexari | investorshub | 04/27/2023 10:41:53 PM |
Really | Vexari | investorshub | 04/27/2023 9:59:45 PM |
Florida surgeon general altered Covid-19 vaccine analysis to | axelvento | investorshub | 04/27/2023 4:30:40 AM |
Government involvement | Vexari | investorshub | 04/26/2023 8:31:50 PM |
Construction commences at Moderna Innovation and Technology Centre | axelvento | investorshub | 04/26/2023 11:56:40 AM |
imo...i have millions upon millions of quiet followers | IHuser | investorshub | 04/22/2023 3:12:27 AM |
Bancel's sell program has been consistent. Selling | FooBarAndGrill | investorshub | 04/20/2023 6:15:56 PM |
Moderna and IBM- | axelvento | investorshub | 04/20/2023 12:06:20 PM |
RSV vaccine approval should be a top priority | axelvento | investorshub | 04/20/2023 11:57:24 AM |
They just wanted to drop the price so | Civil War General | investorshub | 04/18/2023 11:08:13 AM |
News, Short Squeeze, Breakout and More Instantly...
On CNBC's “Mad Money Lightning Round,” Jim Cramer believes in Moderna, Inc. (NASDAQ:MRNA). On May 14, Evercore ISI Group analyst C...
2024-05-14 06:35:00 ET Investors have put their hopes in Moderna 's (NASDAQ: MRNA) next potential product, a respiratory syncytial virus (RSV) vaccine. That's because it represents a new revenue stream for a company that until now has relied on just one product, and a product strugg...
Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 27.7% on an annualized basis producing an average annual return of 40.43...